Hopp til hovedinnhold

Juvenil myoklon epilepsi (JME)

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Hirsch E, French J, Scheffer IE, Bogacz A, Alsaadi T, Sperling MR, Abdulla F, Zuberi SM, Trinka E, Specchio N, Somerville E, Samia P, Riney K, Nabbout R, Jain S, Wilmshurst JM, Auvin S, Wiebe S, Perucca E, Moshé SL, Tinuper P, Wirrell EC. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022 Jun;63(6):1475-1499. doi: 10.1111/epi.17236. Epub 2022 May 3. PMID: 35503716. PubMed  
  2. Genton P, Thomas P, Kasteleijn-Nolst Trenité DG, Medina MT, Salas-Puig J. Clinical aspects of juvenile myoclonic epilepsy. Epilepsy Behav 2013; 28: S8-14. pmid:23756488 PubMed  
  3. Piazzini A, Turner K, Vignoli A, Canger R, Canevini MP. Frontal cognitive dysfunction in juvenile myoclonic epilepsy. Epilepsia 2008; 49: 657-62. PMID: 18177360 PubMed  
  4. Boesen MS, Børresen ML, Christensen SK, Klein-Petersen AW, El Mahdaoui S, Sagar MV, Schou E, Eltvedt AK, Miranda MJ, Born AP, Uldall PV, Thygesen LC, Cacic Hribljan M. School performance and psychiatric comorbidity in juvenile absence epilepsy and juvenile myoclonic epilepsy: a Danish population-based cohort study. J Neurol. 2022 Sep;269(9):4997-5007. doi: 10.1007/s00415-022-11147-2. Epub 2022 May 20. PMID: 35595971. PubMed  
  5. Delgado-Escueta AV, Koeleman BP, Bailey JN, Medina MT, Durón RM. The quest for juvenile myoclonic epilepsy genes. Epilepsy Behav. 2013; 28: S52-7. pmid:23756480 PubMed  
  6. Crespel A, Gelisse P, Reed RC, Ferlazzo E, Jerney J, Schmitz B, Genton P. Management of juvenile myoclonic epilepsy. Epilepsy Behav 2013; 28: S81-6. PMID:23756489 PubMed  
  7. Gesche J, Hjalgrim H, Rubboli G, Beier CP. Patterns and prognostic markers for treatment response in generalized epilepsies. Neurology. 2020 Aug 14:10.1212/WNL.0000000000010644. PMID: 32817177. PubMed  
  8. Gesche J, Christensen J, Hjalgrim H, Rubboli G, Beier CP. Epidemiology and outcome of idiopathic generalized epilepsy in adults. Eur J Neurol. 2020 Apr;27(4):676-684. PMID: 31838768. PubMed  
  9. Hernández-Vanegas LE, Jara-Prado A, Ochoa A, Rodríguez Y Rodríguez N, Durón RM, Crail-Meléndez D, Alonso ME, Delgado-Escueta AV, Martínez-Juárez IE. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high. Epilepsy Behav. 2016 Aug;61:34-40 . pmid:27300146 PubMed  
  10. Mostacci B, Ranzato F, Giuliano L, La Neve A, Aguglia U, Bilo L, Durante V, Ermio C, Monti G, Zambrelli E, Lodi MAM, Galimberti CA. Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE). Seizure. 2021 Feb;85:26-38. PMID: 33418162. PubMed  
  11. Ballvé A, Salas-Puig J, Quintana M, Campos D, Llauradó A, Raspall M, Fonseca E, Abraira L, Santamarina E, Toledo M. Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women. Acta Neurol Scand. 2021 Apr;143(4):407-412. PMID: 33452703. PubMed  
  12. Liu J, Wang LN, Wang YP. Topiramate monotherapy for juvenile myoclonic epilepsy. Cochrane Database Syst Rev. 2015 Dec 23;(12):CD010008 . pmid:26695884 PubMed  
  13. Baheti N, Rathore C, Bansal AR, Shah S, Veedu HK, Prakash S, Kanhere K, Jaiswal SK, Jukkarwala A, Murthy JMK, Radhakrishnan K. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road. Seizure. 2021 Sep 1;92:112-117. PMID: 34496330. PubMed  
  14. Gama AP, Taura M, Alonso NB, Sousa AM, Noffs MHDS, Yacubian EM, Guilhoto LM. Impulsiveness, personality traits and executive functioning in patients with juvenile myoclonic epilepsy. Seizure. 2020 Oct 8;82:125-132. PMID: 33068959. PubMed  
  15. Geithner J, Schneider F, Wang Z, Berneiser J, Herzer R, Kessler C, Runge U.Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.Epilepsia. 2012 Aug;53(8):1379-86. doi: 10.1111/j.1528-1167.2012.03526.x. Epub 2012 Jun 12.PMID:22686598 PubMed  
  16. Syvertsen MR, Thuve S, Stordrange BS, Brodtkorb E. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years. Seizure 2014; 23: 344-8. pmid:24512779 PubMed  
  17. Senf P, Schmitz B, Holtkamp M, Janz D. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors. Neurology 2013; 81: 2128-33. pmid:24212391 PubMed  
  18. Guaranha MS, Filho GM, Lin K, Guilhoto LM, Caboclo LO, Yacubian EM. Prognosis of juvenile myoclonic epilepsy is related to endophenotypes. Seizure 2011; 20(1): 42-8. PMID: 21041102 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Karl Otto Nakken, spesialist i nevrologi, dr med
  • Bernt Engelsen, spesialist i nevrologi, professor dr med